Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

Current evidence suggests that administration of 1,25(OH)2D3 to patients with chronic renal insufficiency results in suppression of secondary hyperparathyroidism only if hypercalcemia occurs. However, since the parathyroid glands possess specific receptors for 1,25(OH)2D3 and a calcium binding prote...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Slatopolsky, E, Weerts, C, Thielan, J, Horst, R, Harter, H, Martin, K J
Formato: Artigo
Idioma:Inglês
Publicado: 1984
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC425405/
https://ncbi.nlm.nih.gov/pubmed/6549016
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares